EUVIMEDObjevte EUVIMED
Systematische ÜbersichtOpen access · CC BY 4.0

Management Strategies for Generalised Granuloma Annulare: A Systematic Review of Current and Emerging Therapies

Luca Bettolini iD, Vincenzo Maione iD, Andrea Carugno iD, Giorgio Stabile iD, Antonio Podo Brunetti, Zeno Fratton iD, Enzo Errichetti, Nicola Zerbinati, Franco Rongioletti, Piergiacomo Calzavara-Pinton iD, Mariateresa Rossi iD, Stefano Bighetti iD

Australasian Journal of Dermatology · 2025

DOI: 10.1111/ajd.14560 ↗

At a glance

Systematische Übersicht in Australasian Journal of Dermatology, 2025. Written by Luca Bettolini and 11 co-authors. Institution: Dermatology Department, University of Brescia, ASST Spedali Civili di Brescia, Brescia, Italy. Major MEDLINE topics: Granuloma Annulare, Dermatologic Agents. Cited 6 times so far (Crossref); 50 references. The full text is freely available (open access, CC BY 4.0).

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Generalised Granuloma Annulare (GGA) is a chronic inflammatory skin disorder with no standard treatment. Since the last review in 2013, new treatments and varied responses have highlighted the need for an updated synthesis to guide clinical decisions. This systematic review aimed to evaluate the epidemiology, comorbidities and treatment outcomes in patients with GGA, synthesising evidence from published studies to provide insights into both conventional and emerging therapeutic strategies. A systematic literature search was conducted in CENTRAL, Embase and PubMed, following PRISMA guidelines. Studies published in English, French or Spanish up to January 15, 2024, were included. Data extraction focused on patient demographics, comorbidities, treatment regimens and therapeutic outcomes. A total of 689 patients were included. The mean age of patients was 52.8 years, with a female predominance (72.6%). Based on this systematic review, we propose a stepwise approach: first‐line treatment includes hydroxychloroquine and phototherapy (PUVA > UVA1 > nb‐UVB). Oral corticosteroids along with high‐potency topical steroids or calcineurin inhibitors may be used in extensive or rapidly progressive disease or as bridging therapy pending slower‐acting agents. Sulfones are second‐line, with oral retinoids (e.g., isotretinoin) as alternatives if contraindicated. For refractory cases, off‐label anti‐TNF‐α agents or JAK inhibitors are recommended, with methotrexate or cyclosporine as valid alternatives. This largest systematic review of GGA treatments offers an evidence‐based clinical framework. While steroids and phototherapy remain standard, emerging options like JAK inhibitors and biologics show promise for refractory cases. Tailored, multimodal strategies may improve outcomes, though further trials are needed to standardise guidelines.

Subjects

MeSH terms (MEDLINE)

Granuloma AnnulareDermatologic AgentsHumansHydroxychloroquineAdrenal Cortex HormonesPUVA TherapyCalcineurin InhibitorsJanus Kinase InhibitorsImmunosuppressive AgentsGlucocorticoidsRetinoids

Author keywords

disseminated granuloma annularegeneralised granuloma annularegranuloma annularesystematic reviewtherapy

Substances

HydroxychloroquineDermatologic AgentsAdrenal Cortex HormonesCalcineurin InhibitorsJanus Kinase InhibitorsImmunosuppressive AgentsGlucocorticoidsRetinoids

Authors and institutions

  • Dermatology Department, University of Brescia, ASST Spedali Civili di Brescia, Brescia, Italy.
  • Department of Medicine and Surgery, University of Insubria, Varese, Italy.
  • Department of Clinical Dermatology, Vita-Salute San Raffaele University, Milan, Italy.
  • Unit of Dermatology, IRCCS San Raffaele Hospital, Milan, Italy.
  • Department of Medicine, Institute of Dermatology, University of Udine, Udine, Italy.
  • Department of Medicine and Technology, University of Insubria, Varese, Italy.

ORCID profiles: Luca Bettolini, Vincenzo Maione, Andrea Carugno, Giorgio Stabile, Zeno Fratton, Piergiacomo Calzavara-Pinton, Mariateresa Rossi, Stefano Bighetti

Cite

APA

Bettolini, L., Maione, V., Carugno, A., Stabile, G., Podo Brunetti, A., Fratton, Z., Errichetti, E., Zerbinati, N., Rongioletti, F., Calzavara-Pinton, P., Rossi, M., & Bighetti, S. (2025). Management Strategies for Generalised Granuloma Annulare: A Systematic Review of Current and Emerging Therapies. Australasian Journal of Dermatology. https://doi.org/10.1111/ajd.14560

Vancouver

Bettolini L, Maione V, Carugno A, Stabile G, Podo Brunetti A, Fratton Z, et al. Management Strategies for Generalised Granuloma Annulare: A Systematic Review of Current and Emerging Therapies. Australasian Journal of Dermatology. 2025. doi:10.1111/ajd.14560

BibTeX
@article{Bettolini2025,
  author = {Bettolini, Luca and Maione, Vincenzo and Carugno, Andrea and Stabile, Giorgio and Podo Brunetti, Antonio and Fratton, Zeno and Errichetti, Enzo and Zerbinati, Nicola and Rongioletti, Franco and Calzavara-Pinton, Piergiacomo and Rossi, Mariateresa and Bighetti, Stefano},
  title = {Management Strategies for Generalised Granuloma Annulare: A Systematic Review of Current and Emerging Therapies},
  journal = {Australasian Journal of Dermatology},
  year = {2025},
  doi = {10.1111/ajd.14560}
}
Start for free →